U.S. investors in Canada's medical marijuana industry are betting they won't fall under the scrutiny of U.S. law enforcement officers, but it's a risky bet. With marijuana still illegal on a federal level in the United States, American investors in Canadian medical marijuana can be seen as violating the Controlled Substances Act, according to some U.S experts. And the use of the banking system to transfer the proceeds of such investments could be seen as money laundering. But some investors said they see little enforcement risk and significant opportunity, given the legal status the industry now has in Canada. The U.S. Drug Enforcement Agency has already been tracking investments made in state-sanctioned marijuana business in the United States. When asked by Reuters about the DEA's view of U.S. investments in Canadian marijuana, DEA spokesman Rusty Payne said the agency is "most interested in those types of activities." U.S. investors have been increasingly drawn to the raft
↧